Literature DB >> 3000660

Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.

J C Craig, S A Hawkins, M W Swallow, J A Lyttle, V H Patterson, J D Merrett, M Haire.   

Abstract

T lymphocyte control of Epstein-Barr virus (EBV) infection of autologous B lymphocytes was examined in parallel to the enumeration of subpopulations of mononuclear cells in 22 multiple sclerosis (MS) patients and in 22 healthy individuals. All were seropositive for EBV. The incidence of lack of T cell control was significantly higher in patients than in controls, confirming previous published work. In the present study, we have shown in addition a significantly reduced proportion of OKT8+ cells and a significantly increased ratio of OKT4/OKT8 cells in the group of patients with lack of control. The findings point to abnormal immunoregulation in MS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000660      PMCID: PMC1577275     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

1.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.

Authors:  D J Moss; A B Rickinson; J H Pope
Journal:  Int J Cancer       Date:  1978-12       Impact factor: 7.396

Review 2.  Significance of virus antibodies in multiple sclerosis.

Authors:  M Haire
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

3.  Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro.

Authors:  D J Moss; J H Pope
Journal:  J Gen Virol       Date:  1972-11       Impact factor: 3.891

4.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

5.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

7.  Suppressor cell function in multiple sclerosis: correlation with clinical disease activity.

Authors:  J P Antel; B G Arnason; M E Medof
Journal:  Ann Neurol       Date:  1979-04       Impact factor: 10.422

8.  Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis.

Authors:  P A Neighbour; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

9.  Lymphocyte subpopulations in patients with multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

10.  Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.

Authors:  G Miller; M Lipman
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  9 in total

1.  Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

Authors:  P J Hughes; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

2.  Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D Donati; P Annunziata; G C Guazzi; D Boraschi; A Tagliabue
Journal:  Ital J Neurol Sci       Date:  1990-02

3.  Circulating T-cell populations during mercuric chloride-induced nephritis in the Brown Norway rat.

Authors:  C Bowman; C Green; L Borysiewicz; C M Lockwood
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

4.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

5.  Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.

Authors:  Michael P Pender; Peter A Csurhes; Casey M M Pfluger; Scott R Burrows
Journal:  BMC Neurol       Date:  2011-08-03       Impact factor: 2.474

6.  CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.

Authors:  Michael P Pender
Journal:  Autoimmune Dis       Date:  2012-01-24

7.  Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Casey Mm Pfluger; Scott R Burrows
Journal:  Mult Scler       Date:  2014-05-19       Impact factor: 6.312

Review 8.  Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.

Authors:  Michael P Pender; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2014-10-31

9.  Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Jacqueline M Burrows; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2017-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.